Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06208605 · ClinicalTrials.gov registry record · NA

Innovations in Personalizing Treatment Study

A NA study of Eating Disorders, sponsored by University of Louisville.

Recruiting
Registry status
NA
Development phase
320
Enrollment target
1
Study location

NCT06208605 is a NA study of Eating Disorders that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 320 participants, roughly in line with the 314-participant average among 37 other Eating Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06208605, a NA study of Eating Disorders, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
NA
Development phase
320 participants
Enrollment target
1
Study location

Study Summary

Eating disorders (EDs) are serious mental illness: someone dies of an ED every 52 minutes. EDs are highly related to a host of negative outcomes, including public health and individual disease burden, medical and psychological comorbidities, and social determinants of health (SDOH). Treatment response for EDs are suboptimal; there are no evidence-based treatment for adults with anorexia nervosa (AN) or Other Specified Feeding or Eating Disorder (OSFED) and only 50% of adults respond to current evidence based treatments. There are no precision treatments, nor any treatments that consider social context, in existence. Personalized treatments for EDs, that consider social contexts, are urgently needed to improve treatment response and minimize the suffering associated with these illnesses. The investigators' overall goal, extending upon their past work, is to create a treatment personalized based on idiographic (or one person) models (termed Transdiagnostic Network Informed Personalized Treatment for EDs; T-NIPT-ED). The investigators will carry out a two-phase study to systematically characterize individual mechanisms of treatment (Phase I: N=900) and then test the efficacy of each treatment module (Phase II: N=240 drawn from Phase I) compared to the current gold-standard treatment (Cognitive Behavioral Therapy Enhanced: CBT-E). The study goals are to (1) characterize the prevalence of T-NIPT-ED precision treatment mechanisms and medical and psychological comorbidities (e.g., obesity; depression), individual disease burden (e.g., disability), SDOH (e.g., food insecurity), and public health outcomes (e.g., service utilization) specific to these mechanisms, (2) identify if personalized target mechanisms improve when matched to evidence-based treatment modules of T-NIPT-ED and (3) test if change in T-NIPT-ED is associated with improved outcomes (vs CBT-E), including ED outcomes, comorbidities, disease burden, and public health outcomes and if these outcomes are moderated

Conditions Studied

Interventions

  • BEHAVIORAL Transdiagnostic Network Informed Personalized Treatment
  • BEHAVIORAL Enhanced Cognitive Behavioral Therapy for Eating Disorders

Study Locations (1)

Kentucky

  • Eating Anxiety Laboratory and Clinic - Louisville

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2024-01-21
Est. Completion 2029-02
Phase NA

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT06208605

The ClinicalTrials.gov registry entry for NCT06208605 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 314-participant average among 37 other Eating Disorders trials with a reported enrollment target. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Eating Disorders appearing as the primary indexed condition, and to 2 interventions - of which Transdiagnostic Network Informed Personalized Treatment is the first listed.

NCT06208605 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT06208605 about?

NCT06208605 is a clinical study titled "Innovations in Personalizing Treatment Study". Eating disorders (EDs) are serious mental illness: someone dies of an ED every 52 minutes. EDs are highly related to a host of negative outcomes, including public health and individual disease burden, medical and psychological comorbidities, and social determinants of health (SDOH). Treatment respon...

What is the current status of trial NCT06208605?

This trial is currently recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2024-01-21. Estimated completion is 2029-02.

What conditions does trial NCT06208605 study?

This clinical trial studies the following conditions: Eating Disorders.

What interventions are being tested in trial NCT06208605?

The interventions under investigation include: Transdiagnostic Network Informed Personalized Treatment (BEHAVIORAL), Enhanced Cognitive Behavioral Therapy for Eating Disorders (BEHAVIORAL).

Who is sponsoring clinical trial NCT06208605?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06208605 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eating Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.